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ABSTRACT 
Natural Killer Cell Activity and Beta - Endorphin in 
the Mink (Mustela visonl and the ~ Vitro 
Effect of Beta- Endorphin in 
Immunologic Assays 
by 
Nancy Cathleen Pace, Master of Science 
Utah State University, 198 4 
Major Professor : Dr. Reed P . warren 
Department: Biology 
Progra m: Toxicology 
The purpose of this study was to investigate natural 
killer cell activity and the possibile role of beta -
endorphin in a natural model of autoimmune orchitis , the 
d a rk mink . 
An assay was developed to study natural killer cell 
activity in the mink and base - line levels of activity in 
this specie were determined . Natural killer cell activity 
wa s assessed in fertile mutation mink, primary infertile 
dark mink and secondary infertile Utah dark mink with 
autoimmune orchitis. The study included three sampling 
xi~ 
times: November, March and April . Natural killer cell 
activity was significantly lower in mink studied in April 
than it was in . mink studied in March or November, and 
there was a significant correlation of activity to 
fertility. The addition of beta - endorphin to natural 
killer c ell cultures had no effect on activity . 
A preliminary study was done to determine 
concentration levels of beta - endorphin in mink plasma, 
pituitary, hypothalamus and testes. Measurable amounts 
were found in all tissue types studied . Although the 
number of samples was too limited to draw significant 
conclus i ons, there appears to be a trend toward lower 
beta-endorphin concentration, in pituitary tissue and 
plasma samples, of mink with autoimmune orchitis. Beta-
endorphin levels did not appear to correlate with natural 
killer cell activity in the mink. 
Two assays, the natural killer assay and the blasto-
genesis assay, were used to insure that the beta-endorphin 
preparation used in this study were active. Natural 
killer cell activity had been reported to be enhanced by 
the addition of beta-endorphin. I n the present study 
natural killer cell activity of hu man peripheral blood 
mononuclear cells (PBMCI was enhanced in the presence of 
xiii 
betaendorphin , suggesting that the peptide was active. 
In addition, the blastogenic response of human PBMC was 
enhanced by the addition of beta-endorphin to cultures in 
the present study . 
(123 Pages) 
INTRODUCTION 
The complex regulation of the immune response has 
been given considerable attention in recent years. An 
array of suppressor and helper cells have been shown to be 
important regulators. In addition to intra - system 
regulation , evidence for inter - system regulation between 
the neural , endocrine and immune systems is mounting . 
Beta - endorphin , a possible actor in inter - system 
regulation, was the focus of this study. 
Physical and e motional stress has often been recog -
nized as an important element in the onset and outcome of 
disease. The mechanisms involved in alteration of the 
immune response under stress are not known . Endocrine 
responses include increased secretion of beta - endorphin 
and adrenocorticotropic hormone (ACTH) (Guillemin et ~ · , 
1977) and increased blood levels of beta - endorphin (Ros -
Sler et ~., 1977) . The cellular target for ACTH is pre -
sumed to be t he adrenal cortex, resulti ng in i ncreased 
secretion of adrenocorticosteroids which are known sup-
pres - sants of the i mmune response in many species (Talal , 
1980) . The cellular target for beta - endorphin has not 
bee n defined (Herz et ~·· 1980 ) but there is increasing 
evidence that cells participating in the immune response 
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may be at least one cellular target of circulating beta-
endorphin. The functional significance of this target 
site could be neuroendocrine regulation of the immune 
response. 
There are in vitro methods for studying regulation of 
the immune response. The autol ogous mixed lymphocyte 
reaction (AMLR) mea sures the in vitro pro 1 if era ti ve 
response of T lymphocytes to autologous non -T stimulator 
cells. Although the significance of the AMLR ~s 
controversial, it may represent an intra-system regulatory 
role or in vivo interactions which may be altered in some 
disease states (Sa kane and Green , 19 79; Housman, et 
~.,1981; and James et ~., 1981). This makes it a useful 
tool for investigating the influence of 
endogenous or exogenous substances on immuno - regulation. 
An in vivo system is the ideal way to study the 
possible involvement of a particular 
regulation of the immune response . The 
substance in 
mink Mustella 
vison , specifically the dark strain of mink, was chosen 
for this study. This strain of mink was chosen for two 
reasons: it suffers a 30% neonatal mortality (Ellis, et 
a l. 19 8 0) which appears to be due to increased 
tion of beta - endorphin (McMullen, 1983), and its 
produc-
adult 
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males exhibit a 20 - 30% i nfertil ity rate . The infertility 
is of two types ; a hypothalamic - pituitary dysfunction 
(primary infertility ) and autoimmune orchitis (secondary 
infertility) (Tung et ~-, 1981 ; Tung et ~- , 1984) . Since 
increased levels of beta - endorphin appear to be involved 
in neonatal kit loss, it is conceivable that i ncreased 
adult levels of this protien contribute to the 
pathogenesis of the infertility. 
The natural killer cell is a possible target for 
circulat ing beta - endorphin . The i n vitro act ivity of this 
cel l population is modulated by beta-e ndorphin (Ma thews et 
~' 1983) and stress (Shavit et ~. , 1984) . Regulatory T 
cells are another possible target for hormonal regulation 
of the immun e response, as the in vitro activity of t hese 
cell types have also been shown to be modulated by beta -
endorphin in some species (Gilman et al ., 1982; McCain et 
~-' 1982) . 
Since the mink is not a well developed i mmunologic 
mode l , it was important to establish normal in vitro 
i mmune activity . Natural killer activity and the blasto-
genic response to the T- cell mitogen PHA was assayed i n 
dark mink with primary and secondary infertility and in 
fe rti le mutation mink. If d ifferences exist between t hes e 
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groups it would suggest a genetic difference in immune 
function. Color genes in the mink are thought to segre-
gate with immune function genes (Porter et ~.,1980). It 
is reasonable to assume that the dark mink carries a 
mutated immune function gene, closely linked to fur tex -
ture or color genes, which may be responsible for the 
autoimmune orchitis. 
This study had two goals . The first was to investi -
gate the effect of beta-endorphin in regulation of the 
immune response . The AMLR was the assay of choice for this 
purpose . Because it is not presently technically possib l e 
to use min k cells jn this assay so human peripheral 
blood mononuclear cells were used for this portion of the 
study. The second goal was to determine if beta - endorphin 
contributes to the pathogenesis of prlmary or secondary 
male infertility in the dark mink . To accomplish this 
goal in vitro immunologic activity and plasma and tissue 
levels of beta- endorphin were investigated in infertile 
dark mink of both infertility types and in a fertile 
mutation color phase . 
The specific objectives of the study were as follows: 
1. To ascertain if human AMLR activity could be 
altered by addition of beta - endorphin to cultures, 
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thereby establishing a link between inter- and 
intra- system regulation of the immune response . 
2. To develop a natural killer assay for the mink. 
3 . To determine normal levels of natural killer 
activity and T cell blastogenesis in dark male mink 
with prlmary and secondary infertility and in 
fertile mutation mink. 
4 . To ascertain if natural killer or blastogenesis 
activity in the mink could be altered by addition 
of beta - endorphin to the in vitro assays . 
5 . To determine normal levels of beta - endorphin in 
plasma , testes, hypothalamus, and pituitary of dark 
male mink of the two infertility types and in a 
different color phase . 
6. To ascertain if differences in beta- endorphin 
concentration in plasma or tissues correlates with 
differences in in vitro i mmune 
infertility type or color phase . 
activity, 
Investigation of the relationship between the neural , 
endocrine and immune systems is the first step to a more 
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complete understanding of the effect of the environment on 
regulation of the immune response. Development of a 
natural animal model to aid that investigation could be a 
consequence of this study. If plasma or tissue levels of 
beta-endorphin differ between infertility types or between 
color phases this pilot study could be enlarged and 
efforts directed toward screening tests to assist in the 
selection of breeding stock . 
Page 7 
REVIEW OF LITERATURE 
Introduction 
Neuroimmunoendocrinology is not a new idea . Blalock 
(1984) recently reviewed the subject. As early as 1935 
Hammar . had reported innervation of the thymus and by 1945 
Kunz and Richins reported innervation of the bone marrow . 
Innervation has since been demonstrated in the lymph nodes 
by Livett et ~- (1968) . These studies , and others. , 
establish the existence of an appropriate anatomical 
environment for interaction between the neural and immune 
systems . 
The interferons are a family of proteins that share 
the capacity to interfere with the replication of viruses . 
Produced by leukocytes , lymphocytes, and fibroblasts, they 
are important in limiting the spread of viruses within the 
host . Many researchers have demonstrated in vitro and in 
vivo modulation of immune function by interferon, the most 
well studied of which is the enhancement of natural killer 
activity (Herberman et al ., 1979; Ortaldo et ~ - , 1981). 
Interferon has also been shown to enhance the lytic 
activity of cytotoxic T cells and to depress the lympho -
proliferative response ofT cells to Con A (Maluish et 
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~-' 1983). 
Evidence for a regulatory circuit between the immune 
and neuroendocrine systems includes a relationship between 
certain of the interferons and th e neuroendocrine 
substances, corticotropin (ACTH) and the endorphins. 
Blalock and Smith (1980) demonstrated strong antigenic 
relatedness among human leukocyte interferon , ACTH and 
endorphins which implies structural relatedness and 
functional similarity. Lymphocytes are known to produce 
ACTH and endorphin-like peptides in conjunction with 
interferon (Smith and Blalock, 1981) . Blalock and Smith 
(1981) have also shown -that human leukocyte interferon has 
potent opioid activity similar to that of the endorphins. 
Stress elicits a variety of behavioral and biochem-
ical responses, including release of 1ncreased amounts of 
beta-endorphin and ACTH into the blood stream (Rossier et 
~- 1977). The studies cited above are only some of the 
evidence suggesting that stress, by stimulating the 
release of substances like . the endorphins , is involved in 
regulation of the immune response. Stress has long been 
recognized as an important element in the onset and out -
come of disease . 
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The Immune Response 
Regulatory and Effector Cells 
The normal immune response is delicately balanced by 
mechanisms of up - and down - regulation . Specific clones of 
cells respond to foreign antigens by proliferating and 
carrying out essential regulatory or effector functions. 
When an organism responds to self antigens as though they 
were foreign, autoimmune disease is the result. Auto -
immune disease is thought , in some cases , to arise from a 
failure of the continual down-regulation of the response 
against self (as discussed by Talal, 1980) . Cells invol -
ved in the immune response include subsets of thymus 
derived, or T cells, and bone marrow derived , plasma, or B 
cells . 
Recent advances have made the elucidation of the 
function of the various immune cells possible. Distinct 
sets and subsets of cells serve as regulators and / or 
effectors of the immune response ; T lymphocytes demon -
strate a high degree of heterogeneity and are involved ln 
regulatory functions as well as effector functions 
(Reinherz and Schlossman, 1979a , 1979b; Re inherz and 
Schlossman , 1980). Sets of regulatory cells include T 
helper , or inducer cells , and T suppressor cells . 
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Cytotoxic T cells are the T cell effectors of the cell 
mediated response and B cells are the effectors of the 
humoral (antibody producing) immune response. 
Kimball (1983) has summarized the current concepts of 
regulation of effector cells. Many regulatory functions 
are mediated via soluble products produced by macrophages 
or lymphocytes. Interferon , Interleukin I and Interleukin 
II are exa mples of such mediators. Cytotoxic T- cells are 
regulated by T helper and T suppressor cells (or their 
products). As effectors of cell mediated immunity cyto-
toxic T cells lyse certain target cells , including virus -
infected cells , syngeneic tumor cells , all oge neic cells , 
and cells carrying foreign antigens on their surface . B 
cells , as effectors of the humoral response , are also 
regulated by T helper and suppressor cells in most cases . 
However, some antigens elicit a T- independent response 
from B cells . 
As reviewed by Paul , (1984) all of the cells 
discussed above fit the definition of immune cells . As 
such , only a limited number of clones are capable of 
responding to a g iven antigenic determinant and they have 
a "memory ". Clones are activated by exposure to a speci -
fic antigen . Exposure generally requires an accessory 
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cell (i.e. macrophages and antigen- presenting- cells) 
which presents the antigen to a specific clone of resting 
clones . After a lag time activated clones differentiate 
and proliferate, resulting in primed effector and regula-
tory cells which act to rid the host of the foreign anti-
gen. Subsequent exposure to that antigen will elicit a 
much quicker response because specific clones have already 
been primed to the antigen. This second response demon-
strates "memory". Some cells which participate in 
protecting the host from infection or neoplasms do not 
fit this definition of immune cells. An example of such a 
population of lymphocytes is the natural killer cell . 
Assessing T and B Cell Function 
Stites 
evaluating 
(1980) reviewed methods 
cellular lmmune function . 
available for 
One method of 
assessing T and B cell function is the in vitro blasto -
genesis assay. This is done by the use of mitogens. 
Mitogens, many of which are phytomitogens (plant derived) 
are substances that cause deoxy - ribonucleic acid (DNA) 
synthesis, blast transformation, and ultimate division of 
lymphocytes. They are polyclonal stimulators . To deter -
mlne the degree of stimulation , an estimate of newly 
formed DNA is made by pulsing cultures with tritiated 
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thymidine ( 3H- Tdr) and measuring uptake . 
Many mitogens are effective stimulators of speci f ic 
classes of lymphocytes regardless of the species studied. 
As discussed by St ites (1980), in 1974 Chess, McDermott , 
and Schlossman demonstrated that T subsets and B cells 
could be functionally isolated by use of mitogens. Con -
canavalin A (Con A), a lectin derived from the jack bean , 
Canavalia ensiformis, stimulates T- helper , T-suppressor 
and T- cytotoxic cells. Phytohamagglutinin (PHA), derived 
from the red kidney bean, Phaseolus vulgaris, is primarily 
a stimulator ofT- helper cells , with some effect on T-
cytotoxic and T-suppres sor cells . Pokeweed mitogen, a 
lectin from the pokeweed plant , Phytolacca a mericana , 
stimulates B- cells as well as T-cells . This mitogen is 
not effective for B- cell stimulation in the mouse. Lipo -
polysaccharide (LPS) , also known as endotoxin A, is a 
compound de r ived from a variety of gram negative enteric 
bacteria . This substance is mitogenic for B lymphocytes 
in the mouse but is not very e ffective in the human . 
The Autologous Mixed Lymphocyte 
Reaction (AMLR) 
An agent or disease state which modulates the 
response of regulatory or effector cell s can result 1n 
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loss of control of immune function. Loss of control can 
·result in autoimmune disease or, conversely, failure to 
rid the host of invading pathogens or tumors . An in vitro 
assay, the autologous mixed lymphocyte reaction (AMLR) can 
be employed to assess the regulatory response. 
The AMLR assay is similar to the mitogen - stimulated 
blastogenesis assay discussed above, however , autologous 
non-T cells , rather than mitogens, are used to stimulate T 
cell blast transformation. Human T cells are easily 
recognized by their specific ability to form rosettes with 
sheep red blood cells (SRBC) (Wybran et ~., 1972). This 
characteristic can be exploited to separate T cells from 
non-T cells for many purposes, including the AMLR. 
It is well established that the AMLR measures an 
i mmunologic response of T cells to surface antigens on 
autologous non - T cells . The proliferating T cells in this 
assay fill the criteria of immune cells; they exhibit 
memory and specificity (Weksler and Kozak , 1977). These 
cells include cytotoxic T cells (Van De Stouwe et ~. , 
1977; Miller and Kaplan , 1978; Tomonari , 1980) and 
suppressor cells (Smith and Knowlton , 1979; Sakane and 
Green , 1979 ; Goeken and Thompson, 1982). Helper T cells 
have also been shown to proliferate in this assay (Smolen 
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et ~-, 1981) . Helper cells , or their product Interleukin 
2, and macrophages, or their major histocompatibility gene 
products, are necessary to activate the proliferating 
suppressor and cytotoxic T cells in this assay (Romain et 
~-' 1984) . 
The Significance of the AMLR 
Systemic lupus erythematosus (SLE) is a complex 
multisystem autoimmune disease characterized by a wide 
variety of autoantibodies in the serum. Sakane et ~. , 
(1978) investigated the AMLR in 33 SLE patients. Lympho-
cytes from these patients had a significantly lower 
(p <:. 0 .001) response than cells from normal subjects. In 
the same study the response to the T cell mitogen, Con A, 
was markedly suppressed in SLE patients leading the 1nves-
tigators 
pressor 
to conclude that the defect resides in the 
T cell population . The response to the T 
sup -
cell 
mitogen PHA was not assessed in this study although in 
light of current information (Romain et ~ - , 1984) , it 
would have been informative . 
Myasthenia Gravis (MG) is an auto1mmune attack 
against the acetylcholine recepto r (AChR) at the post -
synaptic nicotinic membrane. It is thought that thymic 
cells bearing AChR antigen may be the pr1mary stimulant in 
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1975) . Recently, Greenberg et ~-MG (Aharonov et ~., 
(1984) studied 22 patients with generalized untreated 
myasthenia gravis. Cells from these patients were hyper -
active in the AMLR, however, treatment by thymectomy 
reduced the AMLR response to normal levels . No attempt 
was made in this study to identify the defective popula -
tion of immune cells. Haynes et ~- (1983) determined 
that the number of helper T cells increased after MG 
patients had undergone thymectomy for treatment of their 
disease. The T cytotoxic and suppressor populations 
remained unchanged as a result of thymectomy . 
Ilfeld et al . (1977) reported that hydrocortisone 
markedly suppresses the AMLR . They also demonstrated that 
thymic factors and human hepatoma - derived alpha feto -
protein does not suppress the response. These authors 
suggest that glucocorticosteroids may participate in regu-
lation of autoreactive T cells in vivo . 
Katz and Fauci (1979) reported that single LV . 
doses of 400 mg of hydrocortisone suppressed the pro -
liferative response of T cells 1n the AMLR. Non - T 
stimulator cells obtained after injection of the cortisone 
had greater stimulatory capacity than non - T stimul ator 
cells obtained before injection . The authors postulate 
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that this effect may be an immune - regulatory mechanism. 
Methyl prednisone injections have also been shown to 
diminish autologous mixed lymphocyte reactivity in normal 
human volunteers (Tak Yan Yu et ~· · 1978). 
The true sign i ficance of the AMLR remains controver -
sial . The above studies are only so me of the evidence 
linking the in vitro assay to a regulatory in vivo 
function . 
Natural Killer Cells 
Herberman and co-workers have contributed much to the 
elucidation of the natural killer cell . As reviewed by 
Herberman and Ortaldo (1981), natural killer cells belong 
to a population of large granular lymphoid cells. As 
mentioned previously 1n this thesis they are effector 
cells but do not fit the strict definition of immune cells 
as discussed above . The natural killer cell is found in 
normal i ndividuals of a wide range of mammalian and av ian 
species . These cells constitute about 5 - 15% of the 
peripheral blood lymphocyte s and splenic lymphocytes 1n 
man and other species. The natural killer cell can lyse 
allogeneic as well as syngeneic tumor cells, and in some 
cases even zenogeneic tumor cells (Herberman and Ortaldo , 
1981) . The mechanism involved in lysis is not clear , but 
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it does require initial binding to the target , followed by 
lysis whi c h may be mediated by neutral serine proteases , 
by phospholipases , or both . Inhibitors of the these 
enzymes block natural k illing. 
The natural killer cell is generally considered to be 
responsible for killing neoplastic cell s as they arise . 
There is also evidence for a role in elimination of 
virally i nfected cells . Herberman and Ortaldo (1981) cite 
a review by Lopez (1980) in which the author presents 
considerable evidence for a role of natural killer cells 
i n genetic resistance to severe infection by herpes sim-
plex type virus in mice . Bancroft et al . (as ci ted in 
Herberman and Ortaldo , 1981) reported that natural killer 
cells may play a role i n protecting mice fro m cytomegalo-
virus i n f ection. A genetic resistance of chickens to a 
herpes virus known as Marek ' s disease may also be related 
to natural killer activity (Lam and Linna , 1981). 
~ Vitro Assess ment of 
Natural Killer Activity 
Natural killer cell activity can be ass a yed i n vitro 
using susceptible tumor cells as targets by the method 
Brunner et al . ( 19 76) . Briefly, tumor cells are first 
allowed to take up radioactive chromiu m and then are 
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incubated with natural killer cells. Killing of target 
cells can be assessed by measuring the amount of chromium 
released from lysed cells . 
Evidence for a Connection Between 
the Neural , Endocrine and 
Immune Systems 
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Allogeneic skin graft survival in the mouse is 
prolonged by stress (Wistar and Hildemann, 1960) 0 The 
usual cause of failure of skin graft is a T cell mediated 
immune response to histocompatibility antigens (Kimball, 
1983) 0 Human patients suffering stressful injury or 
burns exhibit decreased immune responsiveness and sera 
from such patients contain elevated levels of a low mole-
cu lar weight peptide - (less than 10,000 daltons) which 
suppresses the in vitro response of lymphocytes to T cell 
mitogens . This suppression is well correlated with sus -
ceptibility to bacterial, viral, and fungal infections, 
and can have fatal consequences (Wolfe et ~- , 1981) . 
Riley 11981) studied tumor growth and tumor incidence 
in mi ce housed in low stress and chronic stress 
facilities . He reported enhanced growth and 80% higher 
incidence of tumors in mice subjected to chronic st res s . 
These effects are well corre lated to corticosterone levels 
which are elevated in response to stress in rats . 
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The Hypothalamus Connection 
Induced lesions in the hypothalamus can alter the 
immune response . In 1976 Paunovic reported that posterior 
hypothalamic lesions in young rats depressed the subse -
quent humoral immune response in the adult animals (as 
discussed by Martin, 1984). 
Anterior hypothalamic lesions have been shown to 
alter the cell - mediated immune response. Stein et 5l 
(1981) (as discussed by Martin , 1984) induced anterior 
hypothalamic lesions in guinea pigs. Lymphocytes obtain-
ed from these animals after sensitization to tuberculin 
had a decreased T cetl response to PHA and a decreased 
response to purified protein derivative (PPD) . These 
effects were not due to altered total numbers ofT cells . 
Other evidence linking the hypothalamus to the immune 
response includes suppres s~on of the cutaneous delayed 
hypersensitivity reaction in the guinea pig. Marcis et 
al. (1972) induced tuberal , posterior , and anterior 
lesions ~n gu~nea pigs . They observed a suppression of 
delayed hypersensitivity in response to tuberculin and 
picryl chloride in the animals with anterior hypothalamic 
lesions . 
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The Pituitary Connection 
At least three pituitary hormones; growth hormone, 
prolactin, and ACTH, are known to have an effect on the 
immune response. Beta-endorphin is also released from the 
pituitary. Due to the central importance of beta - endorphin 
to this study a detailed review of its biochemical proper -
ties and its physiological effects is given below in a 
section dedicated to that topic. 
Growth hormone (GH) appears to have a major influence 
on thymus development (Ahlqvist, 1981), as discussed by 
Martin (1984), and cortical thymocytes are reported to 
carry specific receptors for GH (Arrenbrecht, 1974) . 
According to Martin (1984) Ahlqvist has also suggested 
that prolactin may direct lymphoid cells to the mammary 
gland. 
The influence of ACTH on immune function has been the 
subject of much investigation . ACTH is released from the 
pituitary during stress. Its function is , presumably, to 
signal the adrenal cortex to produce increased quantities 
of cortisone (Riley, 1981). As reviewed by Webb and 
Winkelstein (1980) corticoids in high concentration damage 
lymphocytes and thymus elements essential for cell 
mediated defense and surveillance . Lymphoid cells in the 
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mouse, rat and rabbi t are particularly susceptible to cor -
ticosterone injury, and although mature lymphocytes in the 
adult human are relatively resistant to damage by 
corticoids in quantities induced by most stressors (Ta lal, 
1980) ' the human thymus is sensitive to steroids and 
stress-induced levels can result in stress-involution 
(Kimball , 1983) . 
Wolfe et ~- , (1981) and Constantian et al . , ( 1977) 
demonstrated that patients suffering trauma, burns and 
cancer often have normal ly mphocyte counts , but exhibit 
decreased in Vltro immune response which 1s well 
correlated with decreased resistance to bacterial, viral 
and fungal infection and which can have fatal conse-
quences. Normal numbers of immune cells argue against ACTH 
as being the cause of the depressed immune response and 
the presence of a suppressive , endogenous polypeptide, has 
been suggested . 
The Neuropeptide Connection 
Included among neuroactive peptides are hypothalamic 
regulatory factors , anterior pituitary hormones , gut 
hormones, substance P , endorphins , enkephalins, somata -
statin, etc . Substance P has been suggested to have an 
influence on the delayed hypersensitivity and on the 
Page 23 
local inflammatory response (MacClean and Reichlin, 1981), 
as discussed by Martin (1984). 
Beta-Endorphin 
Biochemical Characteristics of 
Beta- Endorphin 
Mains and Eipper (1978, 1979) showed that beta-
endorphin and ACTH are biologically active polypeptides 
which are processed from a large glycoprotein molecule. 
Crine et al. (1979) ca lled this precursor proopio-
melanocortin. Beta-lipotropin (beta-LPH) is the immediate 
precursor of beta - endorphin. Beta - endorphin represents the 
COOH-term inal sequence of that molecule and has a molecu -
lar weight of approximately 3500 daltons . Eipper and 
Mains (1980) concluded that peptides originating from 
beta-LPH include gamma - LPH (beta - LPH 1 - 58 J, beta-
melanocyte stimulating hormone (beta-MSH) (beta-LPH 41 - 58 ) 
and beta-endorphin (beta-LPH 61 - 91 ) . There is a met-
enkephalin sequence in beta-LPH but there is no evidence 
that it acts as a precursor for that molecule (Morley , 
1981) . 
Bloom et al. (1977) showed that beta-lipotropin, 
beta - endorphin and ACTH are present in the same cells 1n 
the anterior lobe of the pituitary. It was Guillemin et 
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al. (1977) who demonstrated that beta - endorphin and ACTH 
are secreted concomitantly in increased levels from the 
anterior lobe of the pituitary in response to acute stress 
or adrenalectomy . 
The target site for beta - endorphin has not been 
clearly defined. It has been speculated that the 
gastrointestinal tract may represent the target site but 
there is little direct evidence. The brain is another 
possible target but it is doubtful that significant 
amounts of beta - endorphin can enter the brain via the 
blood flow . Blood levels of beta - endorphin are orders of 
magnitude lower than -those needed to i nduce visible CNS 
effects after systemic injection (as reviewed by Herz et 
~-' 198 0 ). 
The neuroactive properties of 
been intensively investigated . It 
beta- endorphin ha ve 
is one of several 
endogenous oligopeptides that possess pharmacological 
properties similar to those of opioids (Gramsch et ~., 
1983 ). The physiological significance of circulating 
beta - endorphin is thought to be hormonal due to its 
location and stability (Kosterlitz, 1980) . 
According 
opiates differ 
to Kosterlitz ( 1980) ' the 
fro m each other in molecular 
endogenous 
structure 
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resulting in differences in stability and physiological 
function . There are two general classes of endogenous 
opiates; endorphins and enkephalins . The enkephalins are 
short chain peptides which are sensitive to peptidases . 
Beta - endorphin is one of several endorphins. It is a long 
chain peptide, and is relatively resistant to the action 
of peptidases. 
The Importance of Receptor Type to 
the Action of Beta-Endorphin 
Agonists, bind to specific receptors on cells. This 
binding results in alteration of the normal state of the 
cellular target . Antagonists for specific receptors will 
block or inhibit the action of agonists. These 
characteristics have been used to study the interaction of 
chemicals with receptors. 
It is generally accepted that there are three types 
of opiate receptor; mu, delta and kappa (Corbett et ~-· 
1982). Mu receptors are preferential binding sites for the 
agonist, morphine , and the antagonists, naloxone and nal -
trexone . Delta receptors are preferred sites for the 
endogenous opiates , methione - enkephalin and leucine -
enkephalin . Recently dynorphin , an endongenous hepadeca -
peptide, was demonstrated to be a specific agonist for the 
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kappa receptor (Corbett et ~ - , 1982; Lord et ~-, 1977). 
Beta -endorphin binds with high affinity to mu and delta 
receptors and to the kappa receptor with lower affinity 
(Kosterlitz, 1980; Corbett et ~·, 1982; and Lord et ~., 
1977). 
The mu receptor is considered to be the classic 
opiate receptor, as it binds the agonist, morphine, and 
the antagonist , naloxone . Classic opiate receptors bind 
endorphins via their amino terminus; non-opiate receptors 
bind via the carboxy terminus of the endorphins (Lord et 
~-' 1977). 
Certain tissues may have only a certain type of 
receptor. The response of that tissue to an agonist is 
determined by the receptor type. Mu receptors predominate 
in guinea pig ileum, delta receptors in the mouse vas 
deferens, and kappa receptors in the rabbit vas deferens 
(Kosterlitz, 1980). 
The physiological response of an animal to an opiate 
agonist depends on the type of receptor to which it binds. 
In the central nervous system chemicals binding to mu 
receptors lead to typical "morphine- like " responses. 
Chemicals interacting with the delta receptor have notably 
less "morph ine - like" activity. Beta - endorphin causes 
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typical opiate responses which are blocked by the mu 
antagonist, naloxone, and causes other non-opiate 
responses which are not blocked by naloxone (Kosterlitz, 
1980; Lord et ~., 1977; Leander , 1983; and Rossier et 
~-, 1977). These findings have been interpreted to be 
evidence for opiate (mu) and non - opiate (delta or kappa) 
binding, respectively, by beta-endorphin. 
Stress elicits a variety of behavioral responses. 
Some are blocked by naloxonfr and are , therefore, known as 
opiate responses , others are non-opiate responses (i .e. 
not blocked by naloxone) . Central analgesia is an example 
of an opiate response (Akil et ~., 1976) ; antinociception 
in response to foot shock is an example of a non - opiate 
response (Snow and Dewey, 1983) . The type of stress an 
animal is subjected to may produce opiate or non-opiate 
physiological or biochemical responses. Lewis et al. 
(1980, 1981) showed that inescapable intermittent foot 
shock in the rat produces analgesia, a typical opiate 
response, which is blocked by opiate antagonists . This 
type of foot shock regimen is thus said to produce "opioid 
stress ". Inescapable foot shock applied continuously 
induces equally potent analgesia , but it is not blocked or 
reversed with opiate antagonists. This type of stress lS 
called "nonopioid stress". 
Beta - Endorphin and Immune 
Function 
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Beta - endorphin appears to interact and modulate the 
in vitro response of some immune cells VLa classical 
opiate and/or non - opiate receptors, depending on the type 
of cell studied . In 1979 Hazum et ~ (1979) demonstrated 
specific non - opiate receptors for beta-endorphin on 
transformed human lymphocytes . McCain et ~. , (1982) 
presents indirect evidence for non - opiate receptors on 
human T lymphocytes. There is also indirect evidence for 
non-opiat.e receptors on· rat T lymphocytes (Gilman et ~-, 
19 8 2) . Non-opiate receptors have been demonstrated on 
human complement complexes (Schweigerer et ~., 1982) . 
Indirect (Wybran et ~-, 1979) and direct (Mehrishi and 
Mills , 1983) evidence exists for opiate receptors on human 
lymphocytes and platelets. Specific opiate receptors have 
also been demonstrated o n human granulocytes and monocytes 
(Lopker et ~., 1980). Indirect evidence for the presence 
of opiate receptors on natural killer cells comes from the 
work of Ma thews et ~-, (1983). 
Indirect evidence for beta - endorphin receptors on 
Lmmune cells has been gained by investigat ion of the 
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response of immune cells to the peptide. Gilman et ~., 
(1982) , reported that beta-endorphin had no effect on the 
response of lymphocytes to the B cell mitogen LPS, but 
enhanced the response, in 12 of 23 rats, to the T cell 
mitogens PHA and Con A. The reseachers suggest the vari-
ability in response to T c ell mitogens may be due to 
inherent differences in optimal mitogen stimulat ion . 
Shavit et al . (1984) used Fisher 344 female rats to 
investigate the effect of stress and injection of morphine 
o n natural killer cell activity. Activity ~as suppressed 
in response to "opio id stress" and high doses of morphine, 
but was not suppresied by "non- opioid stress". Both 
stress-induced and morphine- induced suppression was 
blocked by naltrexone, indicating that endogenous opioids 
were responsible for the stress - induced suppression. 
Mathews et ~ - (1983) studied the effect of beta -
endorphin o n in vitro natural killer activity using 
lymphocytes from four human subjects . The peptide, at a 
10 - 14 molar concentration, enhanced activity by 30%. 
Enhancement was significantly correlated with 1ncreas1ng 
concentrat ions of beta - endorphin, and was blocked by the 
opiate antagonist, naloxone. 
McCain et ~ (1982) reported a suppressive effect of 
Page 30 
beta - endorph in on PHA-induced T cell blastogenesis in 
human subjects. Interestingly this suppression was not 
blocked by naloxone even though indirect evidence for 
opiate receptors on normal human T lymphocytes was 
demonstrated by Wybran et ~· (1979), who investigated the 
effect of morphine on T cell resetting and found decreased 
roestte formation . The inhibitory effect of morphine was 
reversed by naloxone . The suppression observed by McCain 
and co- workers may be due to the non-opiate receptor on 
transfor med lymphocyte described by Hazum et al . (1979). 
The Mink - an Animal Model for Investigating 
the Role of Beta-Endorphin in 
Immune Regulation 
The mink is raised commercially for its 
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fur. 
Through selective inbreeding over forty genetically dis -
tinct color phases have been developed , ranging from near 
black to blue to white. The dark mink is known by various 
names, including standard, black, and dark, and is near 
black in color. Dark mink currently hold the world record 
for the highest price ever paid for mink furs, however the 
selective inbreeding which produced this high quality mink 
has also co - selected for fertility problems . Low produc -
tion in this strain is the result of a 20 - 30% male infer -
tility (Tung et ~·, 1981; Tung et ~·, 1984) and a 30% 
neonatal kit loss (Ellis et ~·, 1980; Ellis et ~·, 
1982) . 
The Male Reproductive Cycle 
Mink are seasonal breeders. Testicular development 
begins in December and is complete by late February at 
which time the sperm are mature (Onstad, 1967). Breeding 
occurs during the first three weeks of March with gradual 
tapering off during the third week. Testicular regression 
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begins at the end of the breeding season (Pilbeam et ~-· 
1979) and is complete by June. 
Infertility in the Dark 
Male Mink 
Male infertility in the dark mink has been well 
characterized by Tung et al. (1981, 1984) to be of two 
general types, prlmary and secondary. Primary infertility 
appears to be due to defective GnRH secretion which is due 
to either abnormal hypothalamic function or its control 
mechanisms; the male is never fertile. Mink with second-
ary infertility are fertile for one or more years. The 
cause is of secondary infertility is most often autoimmune 
orchitis which is characterized by testicular immune com-
plexes and cellular infiltration of the testes (Tung et 
~-, 1981; Tung et ~ - , 1984) . 
Tung et ~- (1981) investigated the relationship of 
anti - sperm antibodies to infertility in the dark mink . 
Mink of all color phases tested developed anti - sperm anti -
bodies; dark mink with autoimmune orchitis did have 
significantly higher anti-sperm antibody titers than 
infertile dark mink without orchitis and fertile mutation 
mink, however many dark mink and mutation mink with high 
levels of serum anti-sperm antibodies were fertile. 
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Tung et ~- (1984) found increased levels of humora l 
anti - sperm antibodies in both fert i le and infertile dark 
mink during late March and early April . Histopathological 
findings indicated that atuoimmune orchitis also develops 
during this period. As mentioned above, this is the time 
period when testicular regression is occurring in the 
mink . The authors speculate that leakage of sperm anti -
gens may occur as the result of a defective blood - testes 
barrier , stimulating the humoral antibody response . 
Although mink with autoimmune orchitis were unique in 
developing immune complexes in the testes it is not known 
whether the complexes are the cause of autoimmune orchitis 
or i ts result (Tung et ~- · 1984) . Tung and co - workers 
have suggested the involvement of a cell - mediated response 
Ln autoimmune orch itis . Experimental allergic orchitis 
(Tung et al. , 1977) and post - vasectomy orchitis in the 
gu inea pig (Tung , 1978) can be adoptively transferred when 
lymphocytes from immune animals are injected into non -
immune animals . Toulett and Voisin (1976) were able to 
transfer the disorder to non - Lmmune animals with immune 
serum, but only with great difficulty. 
The Mink as an Immunologic 
Model 
Aleutian disease (AD) of mink is 
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a complex 
pathogenesis which involves host immune response to a 
persistently infecting parvovirus . The disease may be 
progressive and fatal, or chronic. In the fatal form 
there is a dramatic proliferation of plasma cells 
resulting in high titers of anti - viral antibody . 
Antibody - virus Lmmune complexes induce fatal glomerular 
and vascular lesions . In chronic AD, there is a more 
appropriate antibody response and the animal often 
recovers (Porter et ~. , 1972 ; Porter et ~-, 1980; Larsen 
and Porter , 1975) 
There is evidence that immune function genes 
segregate with color genes in the mink (Porter et ~., 
1980) . Whether AD is progressive or chronic depends on 
the genotype of the mink . Mink homozygous for the 
recessive Aleutian gene invariably die within 3- 5 months 
a f ter infection. Mink not homozygous often survLve the 
disease ; 50% are alive at the end of 1 year (Larsen and 
Porter , 1975; Lodmell et ~., 1973 ; Talal , 1980) . 
Mink with AD have been shown to have a suppressed 
response to the T cell mitogens PHA and Con A, and to have 
a significantly elevated number of lymphocytes bearing 
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surface immunoglobulin (B cells) (Perryman et ~-· 1975) 
Soo Hwan and Wilkie (1981) investigated the proliferative 
response of mink lymphocytes to PHA, Con A, the B cell 
mitogen PWM, and viral antigen. They used three color 
phases of mink: aleutian, pastel and dark . When non -
infected mink of all three color phases were compared , no 
significant difference in blastogenic response was noted . 
Mink were then grouped, without regard to color phase, 
into three groups: non-infected mink, mink with chronic 
disease and mink with progressive disease. Mink with pro-
gressive disease had a significantly depressed response to 
all mitogens. T cell mediated immunity was also depressed 
in mink with progressive disease. The investigators 
speculate that progressive disease may be due to impaired 
T cell function as a result of persistence of AD virus and 
its complexes with ant ibody. This does not explain why 
mink homozygous for the aleutian color gene always die 
from infection with the virus . 
Neonatal Kit Loss 
As mentioned previously , the dark mink suffers a high 
neonatal kit loss. This loss occurs within 48 hours of 
birth. Affected kits are typically moribund and fail to 
nurse . Moribund kits have a normal survival rate if taken 
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from the mother , given fluids and kept warm until 
achieve normal newborn activity ; usually within 
hours. 
they 
24 - 48 
An experimental model has been induced in the rat in 
which mortality rates resemble the natural kit loss in the 
dark mink. Hetta and Terenius (1980) examined the effects 
of naloxone blockade of the opiate receptor during gesta -
tion and parturition in pregnant rats. Neonatal mortality 
thirty- six hours after delivery was sign i ficantly 
increased in rats receiving naloxone at the rate of 0 . 1 
mg/hr from day 17 of pregnancy . The authors postulate 
that at least two poss i bilities may account for this loss . 
Increased pain and stress levels during delivery may have 
resulted in less nurturing by the female or naloxone may 
interfere with the hypothalamus-p ituitary ax is by reducing 
prolactin growth hormone release . Many observations have 
indicated that beta - endorphin plays a physiological role 
in reduction of pain (Teren ius , 1978) and it is known that 
endorphins affect the release of prolactin and growth 
hormone from the pituitary (Meites et ~-· 1979) . 
The dark mink appears to be the antithesis to this 
rat model of neona tal mortal ity . Mc Mu llen (1983) 
established beta - endorphin as one factor in the neonatal 
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mortality. He determined beta - endorphin levels in 
moribund and non - moribund kits and found them to be 
significantly higher in moribund kits . Since ACTH and 
beta- endorphin a re thought to be release d in eguimolar 
ratios from the anterior pituitary (Allen et ~. , 1978; 
Mains and Eipper, 1979, 1981), the possibility of an ACTH 
involveme n t in mortality cannot be overlooked . McMullen 
(1983) postulates that the cause of death may be due to 
increased beta - endorphin and ACTH secretion which act in 
consort to induce depletion of energy stores , hypothermia , 
dehydration and loss of appetite. The possibility o f a 
maternal contribution · to neonatal kit loss must be 
considered , however, when normal kits are farmed out to 
females g~v~ng birth to moribund kits they survive 
normally . This suggests that the causative factor lies 
with the kit rather than the mother. 
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MATERIALS AND METHODS 
Experimental Animals 
All dark mink used in this study were obtained from 
the Fred Pace Mink Ranch , Logan , Utah. All mutation mink 
were obtained from the Parker - Boehme Fox and Mink Ranch, 
Logan , Utah. All mink were housed in open - sided mink 
sheds where they were exposed to the natural environment. 
The mink were fed a standard mink feed prepared by the 
Utah Fur Breeders Agricultural Cooperative plant in Logan, 
Utah . This feed has been refined by Co - op animal nutri -
tionists to achieve maximum physical development , health , 
fur texture , and color. The mink were fed approximately 
225 g of this diet daily and were given water ad libitum . 
Only healthy adult male mink were used in the study . 
Mink were sampled during November, March and April for the 
immunologic study and during March and April for beta -
endorphin determinations on plasma and tissues . November 
subjects IN=l2) were all 7 month old Utah dark male mink . 
March and April mink consisted of three groups: year 
old primary infertile male mink (N=S) , 2 year old 
secondary infertile male mink (N=S), and year old IN=4) 
and 2 year old (N=4) mutation male mink . Peripheral blood 
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from dark mink sampled during November was used to develop 
the immunology protocol. These mink were not sacrificed 
for the study and were judged to be healthy by general 
appearance, activity, and consistency and color of fecal 
droppings. 
By March 20, primary dark mink, 5 secondary dark 
mink and fertile mutation mink had been identified . 
Peripheral blood was drawn from these animals for plasma 
beta - endorphin determinations. These mink were sacrificed 
and selected tissue samples were taken for beta-endorphin 
determinations . Spleen cells from these animals were used 
for immunology studies ~ In addition to the judgement of 
health described for the November mink, these mink were 
further judged for health by gross examination of spleen, 
liver , and carcass fat color . One 2 year old mutation 
mink was excluded from the study due to yellow fat; one 2 
year old secondary dark mink was excluded because of 
enlarged spleen and necrosed liver. 
Experimental Design 
for Mink Study 
Mink were divided into three groups: primary and 
secondary infertile dark mink and fertile mutation mink. 
Fertility was determined by sperm check during breeding 
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season . The sperm check was by vaginal aspiration of 
just-bred females. Primary infertility was judged to 
exist in dark male mink with small testicular size and no 
sperm during 
infertility 
their first breeding season. Secondary 
was judged to exist in dark male mink which 
had been fertile in a previous breeding season but had no 
sperm during the season in which this study was done. 
Mutation mink were considered fertile if adequate numbers 
of viable sperm were observed in the vaginal sample . 
The study included a natural killer cell assay, a 
mitogen - induced blastogenesis assay , and determination of 
beta - endorphin levels fn plasma and selected tissues . The 
intent was threefold: (a) to establish normal levels of 
beta - endorphin and immunologic activity ln the three 
groups, (b) to determine whether a correlation existed 
between plasma /tissue beta- endorphin levels and immune 
function or fertility and (c) to determine if beta -
endorphin would modulate in vitro mink natural killer cell 
or blastogenesis activity. 
The natural killer cell assay has not been reported 
in the literature for mink and was developed for this 
study . Mink natural killer cell activity was measured 
against two tumor lines: a mouse Maloney virus infected 
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T- cell lymphoma cell line (YAC) donated by Dr. Esther 
Hays, UCLA Dept. of Medicine, L.A ., CA., and a human 
erythroid meyologenous leukemia line (K562) donated by Dr . 
Reed Warren, USU, Logan , Utah . Methodologies for both 
tumor lines were the same except for maintenance of the 
cell line. The mink lymphocytes demonstrated no killing 
against the human K562 tumor line. The YAC methodology is 
described below. 
Mink Immunologic Reagents and Controls 
Media 
RPMI - 1640 (GIBCO, ~rand Island , NY) supplemented with 
1000 Units penicillin and streptomycin (GIBCO, Grand 
Island , NY) was used as medium for all i mmunologic 
studies . Medium was supplemented with either autologous 
mink plasma or Fetal Bovine Serum (FBS) (Hyclone, Logan , 
UT) as noted. 
Beta - Endorphin 
was 
Human beta - endorphin (Sigma Chern Co. , St . Louis, Mo . ) 
diluted , upon arrival, in medium to a 10 - 4 molar 
concentration and held at - 80°C unti l used in assays. At 
the time of assay beta - endorphin was serially diluted Ln 
medium so that final molar concentrations ranged from 10 - S 
to 10 - 16 per culture well. 
Control for Beta - Endorphin 
Activ ity 
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The human natural killer cell assay , known to be 
enhanced by beta - endorphin, was run at the beginning and 
end of the mink immunology study to insure the activity of 
the peptide. The methodology was the same as that 
described below for the mink natural killer cell assay 
with the exception that the human meyloid tumor line 
(K562) was used instead of the YAC line. 
Sample Collection and Preparation 
for Immunologic Studies 
Blood was obtained by cardiac puncture after mink were 
anesthetized by intramuscular injection with 0 . 5 to 0.8 ml 
of Ketamine HCl (Vetalar; Parke - Davis, Morris Plains , NJ) 
containing 10% Acepromazine IAyerst Laboratories , Inc . , 
NY) . The puncture site was soaked in alcohol and blood (5 
to 20 ml) was drawn in 0 . 02 ml preservative - free hepa rin 
(Sherwood Medical Industries, St . Louis, Mo . ) per ml of 
blood . Blood was well mixed , transferred to a 15 or 50 ml 
plastic conical tube (Corning Glass Ware, Corning , NY) , 
and centri fuged (CU 5000; Damon /I EC Divis ion , Needham 
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Hts., MA) at 300 X g for 15 minutes to separate cells from 
plasma . The plasma was carefully aspirated and set aside 
for use in immunolgic studies . 
Peripheral Blood Mononuclear 
Cells (PBMC) 
Peripheral blood mononuclear c ells (PBMC) were used 
for the immunologic studies prior to March. The cells 
remaining after aspiration of plasma were resuspended to 
the original volume of whole blood with medium. The 
l ymphocytes were separated and prepared for immunologic 
studies as described below. 
Splenic Mononuclear Cells (SMC) 
Splenic mononuclear cells were used for the March 
and April immunologic studies. After blood collection and 
castration these mink were sacrificed by cervical disloca -
tion . The pelt was immediately removed from the carcass, 
the head bisected from the body and placed on ice. 
Spleens were re moved aseptically and single - cell suspen-
sions were prepared by teas~ng apart the organs into 
medium and aspirating through consecutively smaller (18 , 
23' and 25 guage) hypodermic needles (as described by 
Sharma and Gehring , 1979) . Lymphocytes were then 
separated from other blood cells and prepared for assay by 
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the same method used for separation and preparation of 
PBMC. 
Separation 
Five to 
Lymphocyte Separation and 
Preparation 
ml aliquots of the PBMC suspended in 
medium (from spleen or blood) were care fully layered over 
3 ml aliquots of Ficoll Histopaque-1077 (Sigma), using 15 
ml plastic co n ical tubes (Corning), centrifuged at 440 X g 
for 20 minutes and the interface between the Ficoll and 
medium c arefully as~irated. The PBMC were washed ~n 
medium at 300 X g for 10 minutes , and at 200 X g for 
minutes . The lymphocytes were resuspended in medium and 
0.1 ml of the suspension was added to 0.3 ml of 0 . 1% 
ch rystal violet stain (Sigma) for counting using a 
hemocytometer . 
Preparation 
were 
PBMC to be used for the natural killer cell assay 
adjusted to a cell count of no more than X 10 6 in 
medium supplemented with 20% autologous plasma and he)d 
overnight in an incubator (5200; NARCO, Portland , OR) in 
PBMC to be used for the blastogenic 
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assay were adjusted to a cell count of 5 X 10 6 in medium 
supplemented with 20% autologous plasma. 
The Assays 
Blastogenesis 
Mink lymphocyte blastogenic response to the mitogen 
PHA (GIBCO) was assessed by the standard blastogenesis 
assay. Cultures were run in triplicate in 96 - well flat 
bottom microculture plates (25860; Corning Glass Wares, 
Corning , NY) . The PHA was serially diluted in medium so 
that co ncentrations ranged from 8% to 1.6%. Each well 
contained 5 X 10 5 cells and the appropriate concentration 
of mitogen l n a total volume of 0 . 2 ml per well. Med ia 
without PHA was used for control wells which contained the 
same volume and concentration of cells as the PHA treated 
wells. Plates were incubated for 3 days at 37°C in 5% 
co 2 . For the final 16 hours o f incubation PBMC were 
pulsed with 0 . 5 ~Ci of [methyl - 3H} thymidine (New England 
Nuclear, Boston, MA) dissolved in saline (specific 
activity 6.7 Ci/mM) At the end of culture , cells were 
harvested with an automated harvester (Titertek; Flow 
Laboratories , Inglewood, CA) onto glass fiber filters 
(Flow). The filters were either air dried overnight or 
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dried in a 60°C oven for at leas t 30 minutes. Dried fil-
ters were placed in scintillation vials (7 ml polyethyl-
ene; Fisher Sci., Santa Clara, CA) and a volume of 3 ml 
aqueous scintillation cocktail (ScintiVerse E; Fisher 
Sci., Fairlawn, NJ) was added to each vial . Samples were 
counted in a scintillation spectrometer (Packard Tri Carb 
3003; Pa c kard Instruments, Downers Grove , IL) for 0.1 
minute per vial. The uptake of [ 3H] (as estimated by 
counts per 0.1 minute) by lymphocytes in wells containing 
no mitogen was compared to the uptake into the newly 
formed deoxyribonucleic acid (DNA) of the lymphoblasts in 
mitogen stimulated wells. St imulation was observed if 
labeled thymidine uptake in mitogen stimulated wells was 
greater than in non-s timulated wells. 
Natural Killer Cell Assay 
The standard chromium release assay (as discussed in 
the Literature Review) was used. The basic assay was run 
at constant target cell numbers and varying numbers of 
effector cell s with resultant effector:target ratios of 
50: 1 ' 25:1, 12:1 and 6:1 . 
involvi ng beta - endorphin, 
For the portion of the study 
the effector:target cell ra tio 
was held constant at 25 : 1 with varying molar concentra -
tions of human beta - endorphin (Sigma) added to the 
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appropriate cultures. All effector:target ratios and all 
beta-endorphin concentrations were run ln triplicate ln 
round bottom microtiter plates (25850; Corning). 
The YAC cell line was maintained in medium supplemen -
ted with 5% FBS . The YAC cells were diluted and supple -
mented with fresh med ium at intervals to mainta in them in 
a stage of rapid cell growth and d ivi sion. 
YAC cells were prepared for the assay by first 
washing cells in medium , decanting fluid and adding 100 
pCi of Na[ 51cr] chromate . These cells were allowed to 
take up the chromium f o r 1 hour at 37°C in 5% co 2 , then 
washed X3 in cold med i um at 200 X g for 5 minutes, and 
resuspended in medium at a 10 5 concentration . 
Mink PBMC which had been held in the incubator over -
night were prepared for the assay by washing once ln 
medium . Some of the cells were adjusted to a concentra -
tlon of 10 6 cells per ml in a volume of 0 . 6 ml medium 
supplemented with 20% autologous plasma for use ln the 
basic assay . The remalning cells were adjusted to a 
concentration of X 10 6 cells per ml in medium 
supplemented with 40% autologous plasma for use in the 
beta - endorphin study . At the time of assay 0.1 ml of the 
cells prepared for the basic assay were added to 
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appropriate wells for the 50 : 1 ratio . The remaining 
volume of 0 . 3 ml of prepared cells was diluted with 0.3 ml 
medium supplemented with 20% autologous plasma for the 
25:1 ratio, this was repeated to obtain the rema1ning 
effector : target ratios . For the beta - endorphin study 0 . 05 
ml of the 2 X 10 6 cell concentration was added to 
appropriate wells along with 0.05 ml of the appropriate 
molar concentration of peptide. Spontaneous release was 
assessed replacing the appropriate volume of PBMC with 
medium supplemented with the appropriate concentration of 
autologous plasma. Maximum release was determined us1ng 
0.1 ml detergent (Sapon ~ n; Kodak, Rochester , NY) i n place 
of the PBMC. A volume of 0.1 ml freshly washed, labeled 
YAC target cells , at a concentration of 10 5 cells per ml 
was added to each of the experimental , spontaneous and 
maximum release cultures. 
Cultures were incubated 4 hours at 37°C in 5% co2 . At 
the end of incubation 0.1 ml of the supernatant in each 
well was carefully removed and counted on a gamma - 400 
gamma scintillation counter (Bec kman Instruments Inc . , 
Fullerton CAl. 
Calculations for Natural 
Killer Cell Assay 
The percent release was calculated as follows: 
% release Experimental Rel . - Spontaneous Rel. Maximum Rel. - Spontaneous Rel . 
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X 100 
Radioimmunoassay of Beta- Endorphin 
Levels in Mink Plasma , Pituitary 
Hypothalamus and Testes 
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Plas ma and tissue samples were analyzed for beta -
endorphin by means of radioimmunoassay (RIAl . The assay 
was performed with a commercially available RIA kit 
(Immuno Nuclear Corp . , Stillwater, MN). All assay tubes 
were counted in duplicate in a gamma - 400 gamma scintilla -
tion counter (Beckman) . Beta- endorphin levels were inter-
polated fro m a standard curve . The standard curve was 
obtained from standards supplied with the RIA kits which 
were run in tandem with mink samples. 
The assay procedure had been previously validated for 
use in mink by McMullen (1983) , who found the antibody to 
beta - endorphin de monstrated approximately 50% cross -
reactivity with beta - lipotropin and (as specified by the 
supplier) had no cross - reactivity with alpha - endorphin , 
g amma - endorphin , 
corticotrophin 
dyno r phin , alpha - nee - endorphin , 
(ACTHl, a lpha - melanocyte stimulating 
hor mone (a l pha - MSH) , leucine and methionine enkepha lin . 
Plasma 
Collection of Samp les for 
Radioimmunoassay Study 
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Mink were anesthetized and blood was obtained as 
described for the immunologic studies, with the exception 
that no anticoagulant was used. Blood was centrifuged and 
serum collected and stored in glass containers at -6 0°C 
until beta- endorphin measurements by RIA were performed . 
Testes 
After blood had been obtained castration was per-
formed on mink studied ~ n March and April. The testicles 
were quick-frozen and stored in glass containers at - 60°C 
until beta - endorphin determinations were run . 
Hypothalamus and Pltuitary 
Heads were removed and kept on ice as described 
previously in this thesis . The cranial cavity was opened 
with an electric cast saw (Cast-0 - Vac; Depuy Manufacturing 
Co ., Warsaw , IN), the hypothalamus and pituitary were 
removed, quick - frozen and stored in glass containers at 
- 60°C until used for assay . 
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Acid Ext•action of Beta - Endo•phin 
f•om Tissue 
Testes 
Samples we•e obtained as desc•ibed p•eviously. One 
f•ozen testicle f•om each mink was ~xamined and appearance 
noted. Testicles we•e weighed , cut open and contents 
placed in a glass container on ice. Sub - samples (f•om 
0.05 to 0.1 g•ams) of this mate•ial was subjected to acid 
ext•action as desc•ibed by McMullen (1983). No attempt 
was made to confo•m the sample weights , as beta - endorphin 
levels per g testes had not been p•eviously repo•ted for 
mink . Briefly, the sub- samples we•e homogenized in an all 
glass homogenize• with 10 volumes of ice - cold 0.2N HCl . 
The homogenate was pa•titioned against the acid aqueous 
phase for 4 hou•s at 4°C and cent•ifuged (at 4°C) at 760 X 
g fo• 20 minutes . The cla•ified supe•natant was decanted 
into a clean glass container and quick - frozen at - 60°C . A 
lyophilize• (2 5- SRC - 3; Ve•tis, Gardner , NY) was then used 
to d•y the samples. 
of Krebs buffe• . 
for beta - endo•phin . 
The residue was resuspended ln 1 ml 
This f•action was then assayed by RIA 
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Hypothalamus and Pitu itary 
Frozen hypothalamus and pituitary samples were 
weighed, returned to glass containers and placed on 1ce . 
Each sample was then subjected to the acid extraction 
procedure described above for testicles . 
The Assay 
Beta-endorphin titers in plasma and tissue were 
determined using a commercially available RIA ki t (Immuno 
Nuclear Corp . ) The assay involved two procedures: an 
extraction of beta - endorphin from the sample USlng 
sepharose anti - beta-endorphin and column separation, and 
elution from the co lumn and measurement of the peptide . 
Br ie fly , a rabbit antibody with high sensitivity to 
beta - endorphin , sample and 125 r tracer were added to 
columns and allowed to incubate for 22 hours at 4°C . 
Phase separation was done with a pre - precipita ted complex 
of second antibody , carrier and polyethylene glycol (PEG) 
added in a single step . 
Calculations 
(%) = CPM of Std . or Unknown - CPM of NSB 
B/Bo CPM of 0 Std. - CPM of NSB 
NSB = Non - Specific Binding Control 
Std. = Standards supplied with kit 
0 Std . = Zero Standard supplied with kit 
Interpolation 
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X 100 
Percent B/B
0 
was plotted against beta endorphin con -
centration for each beta- endorphin standard on cycle 
semi - log graph paper. A best- f it line was drawn through 
the points on the graph . Sa mple beta endorphin levels 
(pmol/L) were interpolated from the standard curve . 
Tissue sample results were adjusted to reflect nmol / L/ g of 
frozen organ weight. 
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Human Study 
Experimental Des ign 
Volunteers rang~ng in age from 5 to 45 years were 
used for the human study . Donors included healthy male 
adults and children. Health was judged by general 
appearance and questioning of donor or guardian. Donors 
were excluded from the study if they were taking medica -
tion known or suspected to modulate the immu ne response. 
Reagents and Controls 
Media 
Media was the same as that used for mink immunologic 
studies . It was supplemented with either autologous human 
plasma or fetal bovine serum (Hyclone) , as noted. 
Sheep Red Blood Cells 
Fresh sheep blood was centrifuged at 200 X g for 20 
minutes. Plasma and white cells were carefully aspirated 
and discarded, leaving the red cells . Red cells were then 
washed X with medium. After each wash red cells were 
pipetted from the bottom of the tube , t ak ing care not to 
disturb the media/cell interface. After the last wash 
packed sheep red blood cells ISRBC) were treated with 
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2,Aminoethylisothiouronium Bromide Hydrobromide (AET) 
(Sigma) to stabilize T cell resetting . AET was prepared 
by adding 10 ml double distilled water to 0 . 4 g AET and 
adjus~ing the pH ~o 9.5 with 4N NaOH. 
molarity of approximately 0 .1 43 AET. 
Hemoly~ic Buffer 
This resulted in a 
Ammonium chloride hemolytic buffer was used to lyse 
SRBC contaminating T and non - T cell enriched fractions . 
I~ was prepared by adding 0.838 g NH 4Cl (Sigma) , 0.1 g 
NaHco 3 (Sigma), 0 . 0037 g EDTA (Sigma) , and double 
distilled water added ~o bring the final volume to 100 ml. 
This mixture was autoclaved and maintained at 4°C until 
use . Just prior to use the buffer was warmed to 37°C. 
Beta - Endorphin 
Human beta - endorphin (Sigma) was prepared for assay 
as described in mink immunologic study. The human blasto-
genic response ~o the T cell mitogen PHA , which is 
reportedly suppressed by beta-endorphin (McCa in et al ., 
1982) was used to control for beta - endorphin activity . 
The assay was run in tandem with the AMLR on all human 
subjects to insure the activity of the peptide . The 
methodology is described below . 
Sample Collection and Preparation 
for Human Study 
Collection of Peripheral Blood 
Monon,lc l <Oar Cells ( PFlMC I 
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Blood (30-50 ml) was drawn in 0 .02 ml preservative-
free heparin (Sherwood Med ical Industries) per ml of 
blood . Blood was well mixed, transferred to a 50 ml 
conical tube (Corning), and centrifuged at 300 X g for 15 
minutes to separate cells from plasma. The plasma was 
carefully aspirated and frozen for future use. The cells 
remaining after aspiration of plasma were reconstituted to 
th e original volume of -whole blood with medium. 
Separation 
Human PBMC were separated from whole blood by the 
same ficoll/hypaque 
immunologic studies. 
PBMC Preparation 
for the AMLR 
gradient described for mink 
PBMC were used for this assay on the day blood was 
drawn . Cells were suspended in medium supplemented with 
20% FBS and adjusted to a count of no more than 25 x 10 6 
cells per ml. T cell and non-T cell fractions were 
collected by the AET treated SRBC resetting method 
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described below. 
AET Treatment of SRBC 
One volume of washed, packed SRBC was treated with 4 
volumes AET and lef t in a 37°C water bath for 15 minutes 
with occasional gentle mixing. The SRBC were then washed 
~n med iu m X3 at 200 X g for 7 minutes. After the f inal 
wash the medium was careful ly aspirated to leave packed, 
treated SRBC. These cells were adjusted to a 10% cell 
suspension in med ium , and always used within one week. 
Purification ofT Cells 
Separation of lymphocytes from other blood cells by 
the ficoll-hypaque gradient has been described for the 
mink immunologic study. This gradient (with some 
modification) was also used to separate rosetted T cells 
from non - T cells . For this separation all reagents were 
kept at 4°c . In a 15 ml conical tube , a mixture of 1 ml of 
10% AET treated SRBC , 1 ml of human lymphocytes at a 
concentration of no more than 25 X 10 6 total cells , ml 
FBS and 6 ml of cold medium was carefully layered over 3 ml 
of cold ficoll . This tube was incubated at 4°C for 25 
minutes . After this i ncubat ion the cold centrifuge 
carriers containing the tubes were centrifuged at 700 X g 
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for 20 minutes. 
Non -T cells were carefully aspirated from the grad -
lent inter face. The remaining fluid phase was decanted, 
leaving the T cell button . Hemo lytic buffer 12 ml) was 
added to both T and non-T cell fractions. The tubes were 
placed in a 37°C water bath for 15 minutes with occasional 
gentle mixing . After incubation cells were washed X3 at 
200 X g for minutes. After the final wash both frac -
tions were resuspended in medium. Cell counts of both 
fractions were adjusted to 10 6 cells per ml in medium 
supplemented with 20% FBS. 
The Assays 
The AMLR 
The non - T (st i mulator) cells were irradiated with 
137cs for 25 minutes (approx imately 2500 rad) to eliminate 
their ability to respond in the blastogenesis assay . 
Cells were assayed in triplicate in flat bottom micro -
plates (25850 ; Corning) with 10 5 T cells and 10 5 
stimulator cells in a total volume of 0.2 ml medium 
supplemented with 20% FBS. Either varying molar concen -
trations of human beta-endorphin or medium was added to 
appropriate cultures . Cultures to which only medium was 
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added served as a basis to compare cultures treated with 
beta - endorphin. Three .controls were run with the AMLR: 
(a) 0.1 ml T cells plus 0 .1 medium supplemented with 20% 
FBS , (b) 0 .1 ml T irradiated cells plus supplemented 
medium, (c) 0 .1 ml irradiated stimulator cells plus sup-
plemented medium. 
Culture plates were incubated at 37°C in 5% co 2 for 
days. For the final 5 hours of incubation cells were 
pulsed with 0 .5 nCi of [methyl 3H] thymidine dissolved in 
saline (specific gravity 6.7 Ci/mM) (New England Nuclear). 
Cultures were harvested and thymidine uptake estimated as 
described for the mink blastogenesis assay. For this assay 
counts were transformed to log values and triplicates were 
averaged. This log value was used for stat istical analy-
SlS. Log values are valid and useful for long term cell 
cultures , as cell blastogenesis is a logrhythmic function. 
Blastogenesis 
The blastogenic response of T cells to the mitogen 
PHA (GIBCO) was used to control for beta-endorphin activity 
slnce it is reportedly suppressed by the peptide (McCain 
et ~., 1982). Cultures were run i n triplicate in 96 - well 
flat bottom microculture plates (25860; Corning) A 
single concentration of PHA (2%) and varylng molar 
concentrations of beta - endorphin were used . 
contained 10 5 cells, mitogen , and the 
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Each well 
appropriate 
concentration of peptide in a final volume of 0.2 ml per 
well . Control wells were run without PHA or without beta -
endorphin . Culture plates were incubated , harvested and 
counted as described for the mink blastogenesis assay . 
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Statistical Analys is 
Error bars on graphs are representative of the stan -
dard error of the mean (SEM). In some cases results from 
a single representative experiment are presented graphic -
ally and the SEM is for the triplicate values of that 
experiment. In other cases triplicate values were 
averaged; those graphs depict the means of groups and the 
SEM represents differences among individuals of the group . 
The o bserved relative enhancement or suppression of 
activity for the human natural killer cell assay and the 
human blastogenesis assay are presented in graphic form . 
A representative response of the effect of beta -
endorphin on the AMLR is presented graphically . No 
further analysis was necessary for that assay . Regression 
analysis and subsequent analys is o f variance were used to 
determine variation 
concentration levels 
natural killer assays . 
among samples, subjects 
in beta - endorphin - treated 
and 
mink 
Differences in mink natural killer cell activity due 
to seasonal variation, colo r phase and fertility type were 
analyzed by analysis of variance . Significance was set at 
p<O.Ol. 
Determinations of beta - endorphin concentrations in 
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mink plasma and tissue were done as a pilot study . Due to 
the limitations of interpolation from a standard curve , 
some peptide concentrations were either too high or too 
low to assess. These values are presented separately from 
absolute values . The small sample size o f absolute values 
prevents valid statistical evaluation . These results are 
presented i n table form with SEM representing differences 
among animals. 
RESULTS 
Immunologic Activity in the Mink and 
Effects of Beta - Endorphin 
T Cell Blastogenesis 
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Study with this assay was attempted using PBMC 
samples from three dark mink and SMC samples from one dark 
mink and one mutation mink. Pseudamonas c ontamination 
developed in al l culture preparat ions. PBMC were obtained 
from mink which could not be sacrificed for the study and 
although an alcohol wash was used to prepare the needle 
site , the fur value ~ould not be compromised by shaving 
the area prior to cardiac puncture. Spleens were obtained 
on the mink ranches and aseptic conditions were evidently 
not maintained. 
Natura l Killer Cell Activity 
There was a seasonal variation in the level of 
natural killer cell activity in the dark mink from 
November to April . November levels were highest , March 
levels were intermediate and April levels were lowest 
(Figure 1) . The difference was significant at the 50:1 , 
25:1 and the 12:1 effector:target ratios (p <.. O.Ol). 
When natural killer cell activity of dark mink and 
50 -
ffilmJ NOVEMBER 
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Figure 1. S ignifica n t seasonal variat ion (p<O. Ol ) of natural killer 
ce ll a ct ivi ty ln the da 1·k mink. PBMC we re us ed for the assay dur ing 
Nov e mbe r; S MC were u sed fo1 · March and April assays. *Indicates s igni-
ficant diff e rence s by a nalysis of varia nce . 
I; 
I 
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mutation mink were co mpared for the March 20 to April 13 
time period , mutat ion mink had significantly lower 
activity (Figure 2) tha n the dark mink at the 50:1, 25 : 1 
and 12:1 effector : target ratios (p ..( 0 . 01 ) . Whe n these 
results were further broken down by fertility type , 
primary infertile dark (PID) mink had higher levels of 
activity than secondary infertile dark (SID) mink or 
fertile mutation (FM) mink (Figure 3). This difference 
was significant at the 50:1 and 25:1 ratios (p <. 0 . 01). 
The Effect of Beta - Endorphin 
on Mink Natural Killer 
Cell Activity 
A graphical representation of a response of mink 
natural killer cell activity when cu l tured in the presence 
of beta - endorphin is presented in Figure 4. This pattern 
of reactivity was typical o f the response in all of the 
mink (N=28) studied. There was no difference in response 
among groups of mink or between the November and 
March/April sampling times . The variat ion between the 
different peptide concentrations was no greater than the 
variation within triplicate cultures . 
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l owe r· (p<( O. Ol) natur a l ki ll e r· ce ll act i v i ty whe n co mpa r e d to da r k mink 
sa mpl ed d uring Lhe sa met lme pe r iod . *Indicates s i g ni f i c an t d iffe1·ences 
by a na l ys i s o f va ri a nce . 
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F i g ure 3 . Natura l k i ll er ce ll a c tivity was significant l y diffe r ent 
(p ( O.O l) a mo ng pr ima r·y i n fert il e dar k mi nk , seco ndar·y infe rti l e da rk 
mink a nd mu tation mink sa mpled d uring Marc h and April. * Indic ates 
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kill e r c e ll ass ay whe n be ta - e ndo r p hin was add ed to c ul t u1·es at t h e 
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Control for Peptide Activity 
A study was carried out to confirm that the beta -
endorphin preparation used in this investigation had pep -
tide activity. This was done by assessing the effect of 
the peptide on human PBMC in the natural killer assay . 
Beta-endorphin previously had been reported to increase 
natural killer cell activity (Mathews et ~ - , 1983) . 
Figure 5 shows the response of PBMC from two human sub-
jects to incubation with the peptide . · One study was done 
at the beginning of this investigation and one was done at 
the end . 
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fig u re 5 . ·Re l ative enh an ce me nt of natura l kill e 1· ce ll activity of two 
human subjects is evidence of peptide act ivity. 
Limitations 
Beta-Endorphin Concentration in 
Mink Plasma and Tissues 
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A determination of beta - endorphin concentration in 
plasma and tissue samples involved interpolation of values 
from a standard curve (as discussed in Materials and 
Methods). Some samp l es had peptide concentrations too 
high or too low for proper interpolation. Determinations 
were not repeated on these samples since this was a pre-
liminary study and samples were limited . Results from 
these assays are presented as approximate values. A 
variety of orga n samples of different weights were used in 
the assays in order to increase the chance of obtaining a 
measurable concentration of beta - endorphin in the final 
acid extracted sample. 
Plasma 
Plasma levels were run on mink samples obtained from 
March 20 through April 13. Included in the study were 
samples from 7 FM, 4 PID and 4 SID mink. Among absolute 
values there is a trend of FM > PID >SID (Table 1) although 
sample size was too low for any determination of 
significance . 
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Table 1. Plasma beta-endorph i n levels in mink by 
fertility type. Absolute values were interpolated from the 
standard curve; approximate values were either too high or 
too low for a c curate interpolation . 
Absolute Approximate 
Beta-endorphin* Beta-endorphin•• 
Population N (pmoles / L) N (pmoles/L) 
FM 29.38 :!:5 . 18 1 
PID 26.07 :!:8.03 80 
SID 19 . 98 :!:5.15 
*Value is the mean :!: SEM. 
••value i s the beta-endorphin concentration for 1 mink. 
Pituitary 
Determinations were run on 7 FM, 5 PID and 4 SID 
mi nk. Whole pituitar i es, ranging i n weight from 0 . 0 03 to 
0 . 0 1 7 g , were homogenized and used in the assay . Absolute 
values c ould not be interpolated for 1 PID (organ weight 
0 . 005 g) and 1 FM (organ weight 0.017 g). The trend of 
FM > PID >SID correlates to the observed differences in 
p l asma levels among the three groups (Table 2) . 
Hypothalamus 
Determinations i ncluded samples from 7 FM, 5 PID, and 
SID mink. Hypothalamus weights ranged from 0.019 to 
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Table 2. Pituitary beta-endorphin levels in mink by 
fertility type. Absolute values were interpolated from 
the standard curve. In some cases whole o rgans yiel ded 
peptide concentrations too high for accurate interpolation 
and results are presented as approximate values. 
Absolute Approx1mate 
Beta-endorphin* Beta-endorphin** 
Population N (nmoles/g /L ) N (nmoles /g/L) 
FM 7 . 07 !2. 3 3 20.0 
PID 4 5.93 !2. 4 3 16.0 
SID 3.35 !1.21 
*Value is the mean ! SEM. 
**Value is the beta-endorphin concentration for 1 mink. 
0.120 g. Absolute values could be interpolated from 1 FM 
(organ weight 0 . 053 g) , 3 PID (organ weights 0 . 05 g , 0 . 031 
g and 0 . 05 g) , and 2 SID mink (organ weights 0.039 g and 
0 .04 g) , and are presented in Table 3 . In general organ 
weights above 0 . 05g yielded concentrations of beta-
endorphin too high for measuremen t . 
Testes 
Determinations were made o n subsamples of homogenized 
testicular tissue from 7 FM , 5 PID and 4 S I D mink . Testis 
subsamples ranged in weight from 0 . 053 to 0 . 095 g . One FM 
(sample weight 0 . 081 g) and 3 SID mink (sample weights 
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Table 3 . Hypothalamus beta-endorphin levels in mink by 
fertility type. Absolute values were interpolated from the 
standard curve. In some ca ses whole organs yielded peptide 
concentrations too high for accurate interpolation and 
results are presented as approximate values . 
Population N 
FM 
PID 
SID 
Absolute 
Beta - endorphin* 
(nmoles / g/L) 
0 . 81** 
0.15 ±0.03 
l. 5.9 ± 0 . 2 
*Value is the mean ± SEM. 
N 
Approximate 
Beta-endorphin** 
(nmoles / g / L) 
1. 45 
1. 2 3 
1. 46 
1. 3 7 
1. 14 
0.86 
l. 43 
0.26 
1. 43 
1. 04 
**Value is the beta - endorphin concentration from one mink . 
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Table 4. Testis beta-endorphin levels in mink by 
fertility type. Absolute values were interpolated from the 
standard curve . In some cases the sub - sample weight was 
too large , yielding peptide concentrations too high for 
accurate interpolation and results are presented as 
approximate values. 
Population N 
FM 
PID 
SID 
Absolute 
Beta-endorphin* 
(nmoles /g/ L) 
0 .79 ±0.15 
0.71 ±0.19 
0.13** 
Approximate 
Beta-endorphin** 
N (nmoles/g/L) 
0 . 99 
1. 3 3 
1. 13 
1.10 
*Value is the mean ± SEM. 
**Value is the beta-endorphin concentration from one mink. 
0 . 060 , 0 . 071, and 0.071 g) yielded beta - endorphin 
concentrations too high to interpolate. In general, sample 
weights below 0.06 g yielded acceptable concentrations of 
peptide . 
Human Immunologic Studies and the 
Effect of Beta - Endorphin 
Human AMLR 
The AMLR of PBMC from 9 human subjects showed no 
significant modulation when inc ubated in the presence of 
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Figur e 6 . A rep1e sentat iv e examp l e of t h e autologous mlxe J lymph o -
cyte •·espon se of human T ce ll s wh e n c ultured in the presence of 
beta - endo rph i.n. 
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beta - endorphin. A graphical representation of a response 
to the peptide is presented in Figure 6 . 
Human Blastogenesis 
The blastogenic response to the T cell mitogen PHA 
was used to control for beta - endorphin activity 1n the 
human AMLR study. The response to this mitogen has been 
previously reported to be suppressed by the peptide 
(McCain et ~- , 1982) . In the present study a modest but 
significant increase in the proliferative response was 
observed in 8 of 9 assays run in the presence beta -
endorphin. A graphical representation of this effect 1s 
presented 1n Figure 7. The result in one assay was a 
depressed response and a graphical representation of this 
is presented in Figure 8. 
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DISCUSSION 
One purpose of this study was to determine if the 
natural killer cell contributes to the development or 
outcome of autoimmune orchitis in the dark mink. To 
accomplish this a natural killer c ell assay was developed 
for the mink and base-line levels were established . Since 
beta-endorphin has been reported to modulate natural 
kil l er cell activity in some species, the effect of adding 
the peptide to the mink assay was assessed . It was also 
of interest to determine whether measurable levels of 
beta - endorphin were present in the pituitary , hypothalamus 
and testes of the mink, and whether these levels, or 
plasma levels, correlated to infertility in the dark mink. 
Human PBMC were ~sed in the AMLR assay to investigate the 
role of beta-endorphin in regulation of the immune 
response . 
Natural killer cell activity had not been previously 
studied in the mink . The results of this study showed a 
seasonal var1ation in activity from November to April . 
This variation corresponds to the seasonal differences in 
plasma ACTH and beta - endorphin which were reported by 
Mc Mullen (1983) to reach a peak in April , with lowest 
levels i n November, Dec ember and January. ACTH is a known 
suppressant of immune function ( Riley, 
anism of suppress i on is via the 
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1981). The mech -
secretion of 
corticosteriods. Dexamethasone, a synthetic glucocortico-
steriod, inhibited natural killer activity in the human 
(Bray et ~- , 1983) . The same mechanism may play a role 
i n the seasonal dec rease of natural ki l ler ac ti v i ty in the 
mink. 
PBMC were used dur i ng the developmental phase of the 
mink immunologi c invest i gation and SMC were used for the 
March / April portion of the study. This may have 
contributed to the seasonal variation if natural killer 
c ell numbers differ in peripheral blood and spleen. In 
the human natural killer cells account for about 7% of 
PBMC and about 4% of SMC (Herberman and Ortaldo, 1981) . 
Age may have been a possible c ontributing factor to 
the var i ation in natural killer c ell activity seen in the 
dark mink between the November and March / April. Mink 
sampled in November were 8 months of age , those sampled 
during the March/April time period were one and two years 
of age. Age is less likely to be a contributing factor in 
the differences observed between muta t ion mink and dark 
mink, as they were age - matched. 
Beta - endorphin has been shown to enhance natural 
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killer ce ll activity using human PBMC (Mathews et ~· · 
1983) , whereas opioid stress has been shown to suppress in 
the rat (Shavit et ~ · · 1984). In the current study in 
vitro addition of beta - endorphin to cultures had no eftect 
on natural killer cell activity. 
One of the most effective enhancers of i n vitro 
natural k il ler activity is interferon , which shares anti -
genic properties with ACTH and beta-endorphin (Blalock and 
Smith, 1980) . In vivo trials involving interferon injec -
tion in mice and humans have yielded variable effects on 
natural killer cell activity. Several reports have empha -
sized the enhancement of natural killer activity following 
injection of interferon (Santol i et ~· · 1978; Einhorn et 
~·, 1978 ; Golub et al., 1982) . Golub et ~ · (1982) 
reported an i nitial enhancement, followed by a return to 
normal levels of activity , even i n the presence of 
continued administration of interferon. More recently , 
Spina et ~· (1983) reported a s ignificant suppression of 
natural killer cell activity after 5- 6 days of interferon 
injection. Investigation determined that the depressed 
response observed in the assay was not due to a suppressor 
cell population . It is evident from these studies that 
high doses of interferon can result in decreased natural 
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killer activity. The same may be true for beta - endorphin, 
and although this study used concentrations of the peptide 
which have been shown to work in other systems (Mathews et 
~-, 1983; Mcr::ain et ~·, 1982), it is possible that mink 
natural killer cells are not responsive at those 
concentrations. 
The results of plasma beta-endorphin levels in the 
present study agree with those of McMullen 11983) in which 
late March and early April levels were in the range of 19 -
26 pmoles/L . In the current study whole pituitaries gave 
concentrations of beta - endorphin which could be interpo -
lated in all but one of the 16 mink studied . Pituitary 
levels in the three groups of mink paralleled plasma 
levels , with a trend of FM) PID >SID. McMullen looked for 
differences in plasma levels between mutat ion min k and 
dark mink and found none , however he did not attempt to 
look for differences corresponding to fertility types . Of 
interest in both plasma and pituitary levels , i s the 
observation of lower level s of beta - endorphin in mink with 
secondary infertility . If beta - endorphin levels corres -
pond to ACTH levels, and if ACTH acts as a regulatory 
immunosuppressant it may be that there is an i nappropr iate 
increased cell -mediated and/or humoral immune response to 
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testicular antigens during testicular regression in mink 
with secondary infertility. This pilot study would indi -
cate that this mechanism is worthy of further 
investigation . 
Neonatal kit loss in the dark mink is thought to be 
due to increased levels of beta - endorphin (McMullen, 
19 8 3 I . Groesbeck (19811 suggested a hereditary factor in 
He observed that dark mink kits sensitivity to stress. 
were more sensitive to environmental stresses than other 
color phases of mink. As a result of these observations 
and reports of the modulating capacity of 
on the immune system~ high levels of the 
beta - endorphin 
peptide were 
expected to be found i n dark mink with secondary infer -
tility . Interestingly, the current study indicates 
slightly higher beta - endorphin levels in mutation mink 
than in infertile dark mink of both infertility types. 
This suggests that t he neonatal kit loss is not related to 
pr~mary or secondary i nfertility in the dark mink and 
ranchers should select breeding stock by considering them 
separately . 
Measurab le levels of beta-endorphin were found in the 
hypothalamus . This observation agrees with prev~ous 
findings of beta-endorphin-like polypeptides in that organ 
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(Pique et ~., 1981). In the current study homogenization 
and acid extraction of the whole hypothalamus yielded 
concentrations too high for measurement in all but of 
tne 16 mink stud i ed. From these re sults normal levels a re 
in range of 0 . 74 nmol es/g/ L. Future studies should use 
approximately one half of the hypothalamus tissue if the 
same RIA assay kit (New England Nuclear ) is used. 
Measurable concentrations of beta - endorphin were also 
found in mink testes. This ~s in agreement with 
the findings of measurable levels of ACTH and beta -
endorphin in the male reproductive tract of the rat (Tseng 
et ~·, 1982) . Test1cular beta - endorphin levels were 
similar in FM and PID mink . In the one SID mink with a 
measurable concentration of peptide , the amount was much 
less than in the other two groups . However , mink with 
secondary infertility had endorphin concentrations that 
were too high to properly interpolate . Therefore , 
although at face value results may indicate a trend toward 
lower levels in the mink with secondary infertility , a 
reasonab le sample size may have revealed the reverse to be 
the c ase . Further investigation is necessary to determine 
the possible on - site contribution of beta - endorphin to 
autoimmune orchitis . The nu mber of absolute 
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determinations was small due to high concentrations of 
beta-endorphin ~n the acid extracted samples. Future 
studies should use testicular subsamples below 0.05 g if 
the same RIA assay (New England Nuclear) is used . 
The failure of be t a - endorphin to modulate the AMLR 
response in the current study is interesting , since the 
peptide has been previously reported to modulate the 
blastogenic response to the T cell mitogen PHA . The 
reason for a lack of modula tion may reside in the 
i ntr i nsi c differences between mitogen - induced 
blastogenesis and the blastogenic response to autologous 
non-T cells . The former involves presentation of antigen , 
the latter does not. As reviewed by Paul (1984) helper T 
cells co - recognize antigenic determinants and major histo -
compatib ili ty (MHC) determinants on the antigen presenting 
cell s. There is debate as to whether this recognition 
involves one T cell receptor or two receptors . Cells 
responding in the AMLR require MHC determinants but do not 
regu~re antigen to elicit a response 
1984) . 
(Romain et ~· · 
The proliferat ive response of T cells to PHA was used 
as a control for beta - endorphin activi ty in the present 
study. An enhancement of activity was observed in 8 of 
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the 9 assays. This response was not in agreement with 
previously reported suppression by the p e ptide . McC a in et 
al. (1982) reported suppress~on of the blastoge nic 
response of h uman T cells to PH A with the addition of 
beta - endorphin to cell cultures. That study used two con -
centrations of beta - endorphin (10- 7 and 10 - 9 ). Signifi -
cant suppression was o b served with a beta - endorphin 
concentration of 10 - 7 , regardless of the concentration of 
PHA . At a beta - endorphin concentration of 10 - 9 signifi -
cant suppress~on was observed only with a PHA concentra -
tion of 10 p g per well . At this concentration of peptide 
there was a slight , although not significant , enhance -
ment of activity with a PHA concentration of ~g per 
well . The experimental design of that study was similar to 
the prese n t study , with t h e e xception o f the PHA be ing 
used . The current study used unpurified PHA ; actual con -
centration is not known . Although it is possible , it is 
not likely that differences in the direction of modulation 
in t he two studies were due to mitogen c o ncentration. 
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SUMMARY AND CONCLUSIONS 
The purpose of this study was to investigate the role 
of the natural killer cell and of beta- endorphin in auto -
immune orchitis in the dark mink . This was accomplished 
by determining beta - endorphin levels in plasma and 
selected tissues and also by determining the effect of of 
the peptide on the natural killer cell assay. A further 
purpose of this investigation was to determine the regula -
tory role of beta - endorphin in the immune response. For 
this segment of the study human PBMC were used in the AMLR 
assay and the effect of the addition of beta- endorphin on 
response was assessed. 
The natural killer cell activity in dark male mink 
decreased significantly from November to March and from 
March to April. This was not an expected result of the 
study. PBMC were used to develop the natural killer cell 
assay in November; SMC were used for the assay in March 
and April . This study does not establish whether the 
apparent seasonal variation from November to March was due 
to season or sampling site (i . e. spleen or peripheral 
blood). The variation between March and April is evidence 
for a true seasonal variation , however , further investiga -
tion would be necessary to rule out the possibility of 
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other contributing factors. Age is another possible 
factor in the observed difference in activity between the 
November and the March / April sampling times , but is less 
likely to be involved in the March to April decrease in 
natural killer activity, since mink during this sampling 
period were age matched. 
In the present study , mutat ion mink had significantly 
lower natural reactivity tha n dark mink sampled during the 
same time period. When dark mink were divided into 
primary and secondary infertility groups and compared, the 
primary group had significantly higher activity than the 
secondary group. These findings argue against a natural 
killer involvement in the secondary infertile mink. 
However , histopathologic examination of testes was not 
performed in this study, not allowing a direct assessment 
of whethe r there may be natural killer cell involvement in 
true autoimmune orchitis. Future invest igation should 
involve hisopathologic determination of infertility type. 
There are two high mortality seasons for do mest ic 
mink (personal observation). One is late March and early 
April, the other is during late August and early 
September . These losses can be significant in herds 
infected with AD. The lower natural killer cell a ctivity 
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observed in the dark color phase mink corresponds to the 
Mar ch/April loss. The extremely low natural killer cell 
activity in the mutation mink suggests a possible 
mechanis m for the increased susceptibility of that color 
phase to AD . A year long study comparing activity in 
mutation mink and dark mink would be of value in assessing 
the role of natural killer cell activity to AD and 
seasonal losses. 
Beta - endorphin determinations on mink plasma· and 
tissues suggested differences in levels of this peptide 
among FM, PID, and SID mink. The limited number of 
samples yielding absolute beta - endorphin concentration 
levels requires that these results be viewed as purely 
preliminary . The current study should be used as a tool, 
givlng future investigators some idea o f expected levels 
in pituitary, hypothalamus and testes. Plasma levels were 
in agreement with those of Mc Mullen (1983) who suggested 
that further investigation be done co mpar i ng infertile to 
fertile mink. The preliminary results from the present 
study indicate that there may be differences i n beta -
endorphin plasma levels wh ich correspond to fertility . 
Future hormonal studies in the mi nk should consider that 
such differences may exist. 
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Beta-endorphin did not alter the natural killer 
activity in the mink or the AMLR in the human. These 
results cannot be taken as conclusive. Future studies 
should consider cell concentration alterations in both 
assays . 
Control for beta-endorphin activity included a study 
of the abil i ty of the peptide to influence the activity of 
natural killer cells . The results from this study are in 
agreement with those of Mathews et ~- (1983) , who 
observed a dose dependent 30-60% enhancement of activity 
by beta-endorphin , and suggest that the beta-endorphin 
preparation used in this study was active . 
The effect of beta - endorphin on the blastogenic 
response of human PBMC to the T cell mitogen, PHA, was 
used as a control for peptide activity during the AMLR 
portion of the study. Beta-endorphin had been reported by 
McCain et al. (1982) to suppress the response in this 
assay. In the present study 8 of the 9 subjects studied 
yielded a dose - dependent enhancement of activity in tl)e 
presence of beta-endorphin. The protocol for the two 
studies was alike with the exception that McCain and co -
workers used purified PHA. This study used unpurified PHA 
and exact concentrations are not known, and though it is 
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not l i kely to be the c ause of the conflicting results in 
t he two studies, future investigat i on into the effect of 
using varying concentrations of PHA would of value in 
establishing possible causes for the observed discrepancy. 
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Tab le 5 . Analysis of variance t ab le f or seas o nal 
variation in natural killer cell activity at the 50 : 1 ' 
25: 1 ' 12:1 a nd 6 : 1 effector : target ratios . 
50 : 1 
Sou r ce 
of Variation df 55 MS F F (p <.O. 0 1 ) 
Season 11548 . 08 577.04 114 . 00 * 6 . 52 
Error 1 2 606 . 39 50 . 53 
Total 14 12154 .4 7 
25:1 
Season 626 . 65 313 .3 3 7 . 85 * 6 . 52 
Error 12 4 79 . 05 39. 92 
Total 14 1105 . 70 
12 : 1 
Season 349 . 36 17 4. 68 24 . 23 * 7 . 21 
Error 1 1 79 . 3 7 . 21 
Tota l 13 428 . 66 
6: 1 
Sea son 4 2 .09 21. 05 3 . 1 3 7 .21 
Error 11 69 . 99 6 . 3 6 
Tot a l 13 11 2 . 08 
* Ind icate s significant values . 
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Table 6 . Ana lys i s of var i ance table for c olor phase 
var i atio n in natural killer c ell a c tivity at the 50:1 ' 
2 5: 1 ' 12 : 1 and 6: 1 effector:target ratios. 
50 : 1 
Source 
of vari a t i on df ss MS F F ( p ~ O . Oll 
Color 81 7 . 65 81 7 . 65 16 . 73 * 8 . 86 
Error 14 684 . 4 48 . 89 
Total 15 1502.05 
25 : 1 
Color 190.2 190 . 2 12 . 17 * 8 . 86 
Error 14 218 . 86 15 . 63 
Total 15 409 . 06 
1 2 : 1 
Color 49 . 34 49 . 3 4 9. 89 * 8 . 86 
Error 14 69 . 80 4 . 99 
Tota l 15 119 . 14 
6: 1 
Color 2 . 58 2 . 58 0 . 98 8 . 86 
Er r or 1 4 36 . 96 2 . 6 4 
Total 15 119 . 14 
*Ind i c ates significa nt values . 
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Table 7. Analysis of variance table for variation in 
natural killer cell activity, by fertility type , at the 
50:1 ' 25: 1' 12:1 and 6: 1 effector:target ratios. 
50:1 
Source 
of Variation df ss MS F F(p<C0.01) 
Fertility 1201.02 600.51 16.09 * 6.07 
Error 13 485.07 3 7. 31 
Total 15 1686.09 
25:1 
Fertility 832 . 18 416 . 01 39 . 14 * 6 . 07 
Error 13 138.24 10 . 63 
Tota 1 15 981.46 
12: 1 
Fertility 59.41 29.71 6 . 37 * 6 . 07 
Error 13 60 . 64 4.67 
Total 15 120 . 05 
6: 1 
Fertility 3 . 28 1. 64 0 . 59 6.07 
Error 13 36.29 
Total 15 39 . 57 
*Ind icates significant values. 
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Table 8 . Analysis of variance table for mink natural 
killer cell assays treated with beta-endorphin. 
Source 
of Variation df ss MS Coefficients E(MS) 
Subjects 14.89 2.98 1.0 3.0 23.78 
Concentration 42 19.43 0.63 1.0 3.0 
Samples 96 30.34 0 . 31 1.0 
Total 143 64 .66 0 .52 
